UCLA Health’s hospitals in Westwood and Santa Monica have been named to U.S. News and World Report’s 2015-2016 Best Hospitals Honor Roll. UCLA, which previously ranked No. 5 in the country, tied for No. 3 this year.
Our billboards are now up!
Doheny Eye Institute is please to announce that Dr. Deming Sun has received an award from the National Institute of Health/National Eye Institute
Gallery of Zhongshan Ophthalmic Center
Dr. Sadun will be speaking on “Update on Mitochondrial Neuropathy: From Lebers to Linezolid and What these Diseases Teach us about Basic Biology.”
Retina 2016 and the Administrator Program and Nurse & Allied Health Program of Hawaiian Eye kicked off Monday, joining the Comprehensive Ophthalmology Program which started Saturday.
Doheny Eye Institute has an international reputation as a premier research and clinical institution. This is truly a golden age for vision research at Doheny.
Gordon Crary, Jr, played an instrumental role in the growth of Doheny Eye Institute. He was deeply involved with Doheny for decades, going back to our formative years.
As NASA astronaut Scott Kelly returns to earth today after 340 days in space, and heads in for physical tests in Houston, ophthalmologists here on earth are eager to examine his eyes. “If you go up and stay a long time, many things start happening to the eye,” says Dr. Alex Huang.
Dr. Richard L Kasper passed away on March 29, 2016 at the age of 96. Dr. Kasper lived a long and fulfilled life dedicated to his Christian faith, his family, his medical profession and to his Armenian heritage.
Robert K. Maloney, MD, MA, will be giving the annual Ridley Lecture at the 29th International Congress of German Ophthalmic Surgeons in June, 2016.
Originally the Beckman Initiative for Macular Research, Dr. Ryan founded the program with the support of the Arnold and Mabel Beckman Foundation.
We’re pleased to announce the addition of Dr. Michael Ip. Dr. Ip, a retinal surgeon and researcher, will join the esteemed clinical care and clinical research teams at Doheny Eye Institute and the Doheny Image Reading Center (DIRC).
President-elect Donald Trump may just be intent on looking into the future. But it’s clear that he is often squinting. We asked Doheny Eye Institute Dr. John Irvine, a specialist in conditions of the cornea and external eye, to answer a couple of questions about issues for squinters.
Doheny Eye Institute, one of the world’s leading, nonprofit visionresearch organizations, announces the sale of its medical office building at 1450 San Pablo Street in Los Angeles to the University of Southern California. The property is encircled by USC’s health sciences campus.
Doheny Eye Institute’s Alex Huang, MD, PhD, is #1 on The Ophthalmologist magazine’s Power List 2017, a ranking of the most influential people in the field. This year’s rankings focused on the “rising stars” of ophthalmology. Young leaders in ophthalmology were nominated by colleagues, and an expert panel made the final selections to create the annual list.
The 2017 Young Investigator Award recipient, SriniVas R. Sadda, MD, is the President and Chief Scientific Officer of the Doheny Eye Institute, the Stephen J. Ryan – Arnold and Mabel Beckman Endowed Chair, and Professor of Ophthalmology at the University of California – Los Angeles (UCLA), David Geffen School of Medicine.
Gallery of our 48th Annual Doheny Days
Featured in this issue: The Doheny Eye Institute Coffee Table Book, Luminaires Founders Passion for Fashion, Luminaires Jrs. Shake It Up for Doheny Eye Institute, Three New Members Join Doheny Eye Institute’s Board of Directors, Planned Giving Donor John J. Shaak Knows the Risk of Losing Vision
Featured in this issue: Key Successes That Secured Our Future, Glaucoma, Nasa, and Doheny’s Amazing Dr. Alex Huang, A Stem Model Leading The Doheny Image Analysis Laboratory
Gallery of our Fourth Annual Donor Appreciation Event
Gallery of our Festive Fall Fundraiser.
Gallery of our Annual Glaucoma Symposium.
Gallery of Doheny at AAO
Gallery of our Doheny Holiday Reception.
Gallery of our Media Hard Hat Tour of 150 N. Orange Grove, Pasadena.
Gallery of our Society of Scholars event.
Doheny Eye Institute is proud to announce that Vikas Chopra, MD has been awarded the Charles Stewart Warren and Hildegard Warren Endowed Research Chair.
Doheny Eye Institute is proud to announce that Deming Sun, MD has been awarded the Mary D. Allen Endowed Chair in Vision Research. This prestigious faculty position is supported by the generous gift made to the Institute by Mrs. Allen in 1990.
Featured in this issue: Message from the President and Executive Director, Score 2 Study and Translating Studies into Treatment – featuring Michael Ip, MD, Finding signs of Zika virus in infant eyes – featuring Irena Tsui, MD
Gallery of our Luminaires Founders Annual Benefit.
Gallery of the Luminaires Juniors Photo Booth, from the Black & White Ball.
Gallery of the Black & White Ball, presented by the Luminaires Juniors.
Doheny Eye Institute, a top-ranked nonprofit organization proudly affiliated with UCLA Stein Eye Institute and dedicated to furthering the conservation, improvement and restoration of human eyesight since 1947, is pleased to announce the purchase of its new headquarters in Pasadena.
Doheny Eye Institute of Southern California receives local support during its 43rd annual spring benefit raising over $110000.
The bioscience center will potentially serve as a hub for research and clinical collaboration with Doheny Eye Institute, UCLA and California Institute of Technology.
NASA launched the SPECTRALIS with OCT2 Module to the ISS aboard the Antares 230 Cygnus CRS OA-9, also known as Orbital Sciences CRS Flight 9E on May 21, 2018 from Wallops Island, Virginia. The device will be installed on the ISS in late 2018.
On July 18, Braille Institute Los Angeles is hosting a low vision conference featuring speakers from Doheny Eye Institute on aging in place with low vision.
Gallery of our Donor Appreciation Event.
Gallery of our AAO Alumni Reception.
Gallery of our Welcome Reception for Steven Barnes, PhD & Yuhua Zhang, PhD
In 2018, Samuel Asanad was one of three medical students across the U.S. to receive the Jules Stein Research to Prevent Blindness (RPB) Eye Research Fellowship under the mentorship of Doheny neuro-ophthalmologist, Dr. Alfredo A. Sadun, at Doheny-UCLA, and director of neuroscience, Dr. Michael Harrington, at the Huntington Medical Research Institute (HMRI).
Gallery of our Society of Scholars & Alumni Meeting
Gallery of our 2019 Doheny Alumni Dinner
Alex Huang, Assistant Professor at Doheny Eye Institute, will explore the use of aerobic exercise and venous thigh cuff inflation as a countermeasure to SANS.
Gallery of our Donor Appreciation Reception.
Doheny Eye Institute has announced that Charles T. (Tom) Foscue has been elected as Chairman of the DEI Board of Directors.
Doheny and UCLA Stein Eye Institutes proudly welcome Kaustabh Ghosh, PhD, to the scientific faculty as Associate Professor in basic science at the UCLA David Geffen School of Medicine.
Gallery of our Gallery: 4th Annual Doheny-UCLA International Glaucoma Symposium.
Featured in this issue: Preserving Vision on Missions to Mars, Retina Team Looks for Continued Breakthroughs, Dr. Sadun at the Forefront of LHON Research
Gallery of our Doheny-UCLA Retina Symposium.
Gallery of our Luminaires Founders Annual Benefit.
Featured in this issue: New Campus Progresses, Connecting the Dots – Interdisciplinary Science Guides Vascular Research, Glaucoma Success–A Team Effort, Dr. Sun Seeks Disease Triggers
Doheny-UCLA researcher, Yuhua Zhang, PhD, is the most recent recipient of the Catalyst Award from Research to Prevent Blindness
Doheny Eye Institute, a global leader in vision research and basic science to save human eyesight, has announced that Deborah Ferrington, PhD, is joining the organization as Chief Scientific Officer (CSO)
The event welcomed over 350 attendees from the community, elected officials and invited guests with speeches from Doheny CEO, Marissa Goldberg, UCLA Representatives and City of Pasadena Mayor Victor Gordo welcoming Doheny Eye Institute to the community.
Doheny Eye Institute, a global leader in vision research and basic science to save human eyesight, has announced that Molly Ann Woods, CFRE, is joining the organization as Chief Development Officer (CDO)
Featured in this issue: New Campus Progresses, Connecting the Dots – Interdisciplinary Science Guides Vascular Research, Glaucoma Success–A Team Effort, Dr. Sun Seeks Disease Triggers
Doheny-UCLA researcher, Yuhua Zhang, PhD, is the most recent recipient of the Catalyst Award from Research to Prevent Blindness
Doheny-UCLA clinician-scientist, Victoria Tseng, MD, PhD, has been awarded the Career Development Award from Research to Prevent Blindness
To support everyone throughout our workforce and customer base, Doheny Eye Institute now provides enhanced accessibility support online to create a barrier-free user experience.
Dr. Ben Bert discusses two more recalls of eye drops with KNX In Depth’s Charles Feldman and Rob Archer. Learn more about potential contamination risks that could lead to serious injury or vision problems.
The momentum is building as Doheny Eye Institute continues to see a growing spotlight for its contributions to ocular research, exemplified by recent accolades for CEO Marissa Goldberg and Chief Scientific Officer Deborah Ferrington, PhD, from the Los Angeles Business Journal (LABJ).
27 June 2023 Click Here to view Dr. Sadda’s Profile Page – FOR IMMEDIATE RELEASE – Dr. SriniVas R. Sadda named 2023-2024 ARVO President-elect Los Angeles, CA, June 27, 2023 – SriniVas R. Sadda, MD, was recently named president-elect of...
2023 Insight Newsletter – Learn the Power of Collaborative Science
Video Transcript Editor’s note – This transcript has been edited for clarity. David Hutton: I’m David Hutton of Ophthalmology Times. At its annual meeting earlier this year, the Association for Research in Vision and Ophthalmology, named Dr. SriniVas...
Hot tips for protecting your eyes this summer: UV Safety Tips AUGUST With the sun shining brightly, Doheny Eye Institute is here to remind you of the importance of safeguarding your eyes from harmful ultraviolet (UV) rays. UV exposure can lead to serious eye...
Children’s Eye Health and Safety Month AUGUST August is Children’s Eye Health and Safety Month and at Doheny Eye Institute, we believe that healthy eyes pave the way for endless possibilities and vibrant futures. Let’s dive into our top tips to...
Pasadena Magazine recognized Dr. Sadda and Dr. Sadun as Top Doctors in their September/October 2023 issue. View the online flipbook from the publisher using the link below. Read more...
28 August 2023 Click Here to view Dr. Steven Barnes’ Profile Page – FOR IMMEDIATE RELEASE – Steven Barnes, PhD, Selected to Receive Five-Year NIH Research Grant Pasadena, CA, August 28, 2023 – Steven Barnes, PhD, Principal Investigator...
August 2023 Annual Doheny Planned Giving Luncheon On June 6, several of our esteemed donors and guests gathered at Doheny Eye Institute for a special luncheon. This annual event offered our guests the opportunity to learn more about Doheny’s...
Our Chief Scientific Officer, Deborah Ferrington was recently recognized by the Los Angeles Business Journal. In response to the need for quality mental health care for older adults, Ari D. Kalechstein, Ph.D. and his company, Executive Mental Health (EMH) work to...
Modern Retina recently covered our conversation with Ophthalmology Times. There once were no treatment options for age-related macular degeneration (AMD), the leading cause of irreversible blindness in the elderly, but there now are multiple therapies available for...
September 2023 Doheny Closes out 75th Anniversary with Eyes on the Future Last month marked the end of our 75th year, closing out a remarkable time for Doheny Eye Institute – from our founding by Carrie Estelle Doheny in 1947 after she lost the sight in...
October 2023 Dr. Barnes and Dr. Ferrington Jeff Golberg, Doheny CEO Marissa Goldberg, and Jeremy Poincenot and his mother, Lissa Expressing our Gratitude at the Annual Donor Appreciation Event It...
31 October 2023 News: FDA warns consumers not to purchase or use certain eye drops from several major brands due to risk of eye infection. FDA is updating the list of over-the-counter eye drop products consumers should not purchase or use to include Equate Hydration...
21 November 2023 Click Here to view Dr. Ghosh’s Profile Doheny Eye Institute Research Breakthrough: Stiffening of retinal blood vessels threatens vision in diabetes Using atomic force microscopy, researchers at Doheny Eye Institute, an affiliate of UCLA,...
November 2023 Doheny-UCLA Affiliation Marks 10th Anniversary This December we proudly celebrate the 10th anniversary of the Doheny Eye Institute and UCLA Stein Eye Institute affiliation, a fruitful partnership that continues to elevate groundbreaking...
23 October 2023 Click Here to view Dr. Sadda’s Profile Dr. SriniVas R. Sadda Recognized with Retina Research Foundation Merit Award for Groundbreaking Research on Retinal Disease October 14, 2023 — SriniVas R. Sadda, MD, director of the Doheny Eye...
Alfredo A. Sadun, MD, PhD, and colleagues conducted an international post-mortem study of human eyes treated with adeno-associated virus (AAV2)-based gene therapy for Leber hereditary optic neuropathy (LHON). The results were reported at the American Academy of...